The autoinjectors market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to expansion of therapeutic applications, rising healthcare costs, increased focus on patient-centered care, telemedicine and remote patient monitoring, emerging markets. Major trends in the forecast period include personalized drug delivery, connected and smart autoinjectors, needle-free autoinjectors, biologic drug delivery, safety and security features.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report
Segmentation & Regional Insights
The autoinjectors market covered in this report is segmented –
1) By Type: Disposable Autoinjectors, Reusable Autoinjectors
2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies
3) By Route Of Administration: Subcutaneous, Intramuscular
4) By Distribution Channel: Online Retailer, Pharmacy
5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users
North America was the largest region in the autoinjectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autoinjectors market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of chronic diseases is expected to fuel the growth of the autoinjectors market in the coming years. Chronic diseases are described as illnesses that last a year or longer and necessitate continuing medical attention. Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the world’s top causes of mortality and disability. Auto injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosage for long-term management of medical circumstances such as diabetes and rheumatoid arthritis. For instance, according to the Imperial College London research in 2020, chronic diseases are expected to kill almost 41 million people globally each year, accounting for seven out of ten fatalities. Around 17 million of these fatalities are classified as premature, with people dying substantially younger than predicted on average. Therefore, the increasing prevalence of chronic diseases drives the growth of the autoinjectors market.
Key Industry Players
Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc
The autoinjectors market report table of contents includes:
1. Executive Summary
2. Autoinjectors Market Characteristics
3. Autoinjectors Market Trends And Strategies
4. Autoinjectors Market – Macro Economic Scenario
5. Global Autoinjectors Market Size and Growth
……………………..
31. Global Autoinjectors Market Competitive Benchmarking
32. Global Autoinjectors Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Autoinjectors Market
34. Autoinjectors Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://goodprnews.com/surface-active-agents-global-market-size/
https://goodprnews.com/therapeutic-dental-equipment-global-market-size/
https://goodprnews.com/stem-cell-cord-blood-banking-global-market-size/
https://topprnews.com/surface-active-agents-global-market-share/
https://topprnews.com/therapeutic-dental-equipment-global-market-share/
https://topprnews.com/stem-cell-cord-blood-banking-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
